Published on
September 16, 2024
- 05:00 GMT
China patent notification boosts PolTREG’s development of Treg cell therapy in multiple sclerosis
China’s National Intellectual Property Administration has issued notification to grant patent to PolTREG Chinese patent covers intrathecal administration of PolTREG’s PTG-007 Treg cell therapy to treat multiple sclerosis Intrathecal administration …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Law
...
